ProForma 2.0
validated simple linear
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKL
CAP-18_31
Aliases: CAP-18_31, D-CAP-18_31
Normalized sequence
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKL
31 amino acids
Release PepDiana-V1-20260620
44
Activity records
1
Source papers
44
Positive
0
Negative / threshold
Versioned scientific descriptors
No separate physicochemical property was reported in the primary-literature identity record. PepDiana release values are shown as computed properties.
Molecular weight
3729.6451 Da
Molecular formula
C171H311N55O37
Theoretical pI
12
Net charge at pH 7
11.7539
GRAVY
-0.9935
Instability index
31.2806
Aromaticity
0.0323
Topological polar surface area
1575.88 Ų
cLogP
-10.5144
Hydrogen-bond donors
56
Hydrogen-bond acceptors
49
Rotatable bonds
143
Method: PepDiana sequence/structure descriptor pipeline
Tool: Biopython+RDKit · Biopython 1.85; RDKit 2024.09.6
Calculated: 2026-06-20T11:01:38.358971+00:00
Assumptions: ph=7; termini=free N-terminus and free C-terminus for simple linear peptides; stereochemistry=standard L-amino acids; smiles_length_limit=200
ProForma 2.0
validated simple linear
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKL
HELM 2.0
validated simple linear
PEPTIDE1{G.L.R.K.R.L.R.K.F.R.N.K.I.K.E.K.L.K.K.I.G.Q.K.I.Q.G.L.L.P.K.L}$$$$V2.0
Canonical SMILES
validated
CCC(C)C(NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(CC(N)=O)NC(=O)C(CCCNC(=N)N)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)CN)C(C)CC)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)O)C(C)CC
Isomeric SMILES
validated
CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
Paper-level observations
Table 2: CAP-18_31 MIC 8 mg/L against P. aeruginosa strain 121007
Table 2: CAP-18_31 MIC 0.5 mg/L against P. aeruginosa ATCC 121110
Table 2: D-CAP-18_31 MIC 2 mg/L against P. aeruginosa strain 121007
Table 2: D-CAP-18_31 MIC 0.25 mg/L against P. aeruginosa ATCC 121110
Table 3: CAP-18_31 MIC50 2 mg/L against P. aeruginosa strain panel
Table 3: CAP-18_31 MIC90 16 mg/L against P. aeruginosa strain panel
Table 3: D-CAP-18_31 MIC50 4 mg/L against P. aeruginosa strain panel
Table 3: D-CAP-18_31 MIC90 16 mg/L against P. aeruginosa strain panel
Table A1: CAP-18_31 MIC 0.5 mg/L against P. aeruginosa 12-1110 S1
Table A1: D-CAP-18_31 MIC 0.25 mg/L against P. aeruginosa 12-1110 S1
Table A1: CAP-18_31 MIC 0.5 mg/L against P. aeruginosa 21-0505 S2
Table A1: D-CAP-18_31 MIC 0.5 mg/L against P. aeruginosa 21-0505 S2
Table A1: CAP-18_31 MIC 8 mg/L against P. aeruginosa 21-0308 R2
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa 21-0308 R2
Table A1: CAP-18_31 MIC 2 mg/L against P. aeruginosa 15-0803 S3
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa 15-0803 S3
Table A1: CAP-18_31 MIC 0.5 mg/L against P. aeruginosa 15-0307 S4
Table A1: D-CAP-18_31 MIC 0.5 mg/L against P. aeruginosa 15-0307 S4
Table A1: CAP-18_31 MIC 1 mg/L against P. aeruginosa 21-0410 S5
Table A1: D-CAP-18_31 MIC 0.5 mg/L against P. aeruginosa 21-0410 S5
Table A1: CAP-18_31 MIC 8 mg/L against P. aeruginosa 16359347-2 R3
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa 16359347-2 R3
Table A1: CAP-18_31 MIC 1 mg/L against P. aeruginosa 36a
Table A1: D-CAP-18_31 MIC 2 mg/L against P. aeruginosa 36a
Table A1: CAP-18_31 MIC 4 mg/L against P. aeruginosa 38a
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa 38a
Table A1: CAP-18_31 MIC 4 mg/L against P. aeruginosa 27853
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa 27853
Table A1: CAP-18_31 MIC 16 mg/L against P. aeruginosa C1
Table A1: D-CAP-18_31 MIC 16 mg/L against P. aeruginosa C1
Table A1: CAP-18_31 MIC 16 mg/L against P. aeruginosa C2
Table A1: D-CAP-18_31 MIC 16 mg/L against P. aeruginosa C2
Table A1: CAP-18_31 MIC 2 mg/L against P. aeruginosa C3
Table A1: D-CAP-18_31 MIC 8 mg/L against P. aeruginosa C3
Table A1: CAP-18_31 MIC 4 mg/L against P. aeruginosa C4
Table A1: D-CAP-18_31 MIC 8 mg/L against P. aeruginosa C4
Table A1: CAP-18_31 MIC 2 mg/L against P. aeruginosa C5
Table A1: D-CAP-18_31 MIC 4 mg/L against P. aeruginosa C5
Table 4: CAP-18_31 hemolysis IC50 185.26 uM against human erythrocytes
Table 4: D-CAP-18_31 hemolysis IC50 108.44 uM against human erythrocytes
Table 4: CAP-18_31 cytotoxicity IC50 1.31 uM against A549 cells
Table 4: D-CAP-18_31 cytotoxicity IC50 12.32 uM against A549 cells
Section 2.2: CAP-18_31 IC50 13.1 uM against HeLa cells
Section 3: D-CAP-18_31 IC50 6.16 uM against HeLa cells (mentioned in discussion)
Citation and release provenance
Cite this identity as PepDiana record PEPDIA-PLP-001033, release PepDiana-V1-20260620. Experimental observations retain their paper, mention, and activity-record identifiers.
Record updated: 2026-06-22T07:14:26.229247+00:00